Comparison of H1 versus combined H1/H2 antagonist premedication on incidence of rituximab infusion-related reaction: A retrospective cohort study
{{output}}
IntroductionRituximab, an anti-CD20 monoclonal antibody used in B-cell malignancies, is associated with infusion-related reactions (IRRs) during the initial infusion. Standard premedication includes acetaminophen, corticosteroids, and a histamine-1 (H1) antago... ...
